Main Slider

Testing booth aims to ease COVID-19 pressure on frontline

The Industrial Technology Research Institute (ITRI) in Taiwan has developed a positive pressure COVID-19 testing booth to help medical frontlines. The innovation aims to eliminate of cross-infection risk between medical staff and the potential patients. There is no need to wear a full set of protective clothing, thus saving time and energy. A medical frontline worker can put their hands into the patient’s mouth to obtain a throat tissue sample, and even conduct a close consultation with the patient in the testing booth. The testing booth emphasises its safety design by employing a positive pressure technology which allows air only to move from inside to outside, which prevents contaminated air to enter the booth and alleviates the risk for workers taking samples. The testing boo...

How COVID-19 is highlighting the importance of digital health solutions

Matt Norton, director of strategy & client solutions, S3 Connected Health, takes a closer look at a few of the solutions that have been rapidly developed to help battle the pandemic – and how they can help improve healthcare post-COVID-19. Since the beginning of the pandemic the COVID-19 crisis has been highlighting the value that digital health solutions can bring to patients – whether that’s managing patients in their home environments, reducing the burdens and risks associated with travel to clinics, or streamlining care pathways in hospitals. Three digital health solutions helping to tackle COVID-19 1. accuRx To help counter the spread of COVID-19 as patients travel to and from healthcare facilities, accuRx extended free use of its Fleming video consultation tool to all NHS healthc...

NHS Trust trials remote smart patient monitoring

Virtual hospital care start-up Doccla, is partnering with Northampton General Hospital NHS Trust (NGH) to trial remote smart patient monitoring. The company is providing virtual wards, built around the use of connected medical wearables in the home, to allow NGH clinicians to remotely monitor the vital signs of recovering COVID-19 patients and those living with chronic illness.  Doccla was originally chosen by the NHS to lead on a project to demonstrate the feasibility of smart home care. Since the COVID-19 pandemic, NGH has worked with Doccla to develop a remote monitoring system for recovering COVID-19 patients as well as the chronically ill. Patients are equipped with smart devices to wear at home which send information to NGH clinicians to support decision-making. Doccla uses the ...

Cumberlege report uncovers serious wrongdoing

A government ordered review into a range of medical treatments primarily targeting women has uncovered serious wrongdoing by healthcare professionals. The Independent Medicines and Medical Devices Safety Review was ordered by former health secretary Jeremy Hunt in 2018 to investigate the impact three treatments have had on patients. The review covers hormone pregnancy tests including Primodos, the anti-epileptic drug sodium valproate and pelvic mesh implants. Both Primodos and sodium valproate are thought to have caused complications during pregnancy for many women, resulting in birth defects, miscarriages and developmental delay in children.    Patient advocacy groups have been campaigning to have pelvic mesh implants investigated for years after women have called out ...

Collaboration includes digital health tool for asthma treatment

Propeller Health is collaborating with Novartis to co-package the Propeller digital health platform with Enerzair Breezhaler, a recently approved Novartis medication developed to treat uncontrolled asthma. This collaboration marks the first time a digital health tool will be packaged and prescribed alongside an inhaled asthma medication. Enerzair Breezhaler and Propeller sensor and app received approval from the European Commission in July and will launch across Europe starting in 2020. Healthcare professionals in Europe will have the option to prescribe Enerzair Breezhaler with or without the companion digital health platform. Enerzair Breezhaler was approved as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long-acting be...

Webinar to explain how life science firms can approach investors

Medilink East Midlands will be running a webinar explaining how life science companies can pitch to investors. The online event, taking place on Wednesday 15th July, will introduce life science and healthcare SMES and innovators to some of the key factors to consider when approaching private investors for funding.  Alongside speakers from BioCity and the East Midlands Academic Health Science Network, the webinar will cover: What Investors are looking for Why startups fail Finding product-market fit Telling the story There will also be an opportunity to ask questions to the presenters. For more information, or to book a place, click here. Med-Tech Innovation

Team receives £100k for device to protect COVID-19 patient carers

A team who developed a mini-isolation tent to protect carers working with COVID-19 patients has raised a £100,000 investment. Mat Campbell-Hill and his colleagues who created the AerosolShield have secured the funding from the West Midlands Academic Health Science Network’s (WMAHSN) SME Health Innovation Fund, which is managed by Mercia, and MidTECH Innovations. The team put it into production and took the first orders within seven days, and has produced over 1,000 devices for the NHS with the help of £35,000 from a crowdfunding campaign. The latest investment will allow them to set up a new medtech business and scale up production. Campbell-Hill, a senior fellow in novel medical technologies at University of Birmingham, worked with a team including his university colleague ...

Owen Mumford report sheds light on connected drug delivery devices outlook

Owen Mumford Pharmaceutical Services has released a new report assessing the factors driving development and adoption of connected drug delivery devices, and the current attitudes of key healthcare stakeholders towards greater digitalisation in healthcare. With the global connected drug delivery device market projected to grow at over 25% CAGR to reach more than $700 million in 2025, it is important to take a comprehensive view of the potential obstacles associated with these devices and assess how stakeholders can work collaboratively to address them.  With increased demand for therapies treating chronic conditions, acute services risk being overwhelmed unless more patients are able to manage their own treatment and self-administer medication at home. Connected devices can allow clin...

Innovation must be the solution when rebuilding the NHS

Chris Green MP, chair of the All-Party Parliamentary Group (APPG) on Medical Research, believes COVID-19 presents an opportunity for transformative change across the health system, with patients and innovation at the heart of decision-making. NHS England recently announced they were rolling out a state-of-the-art cancer radiotherapy treatment across the NHS. The treatment, called Stereotactic ablative radiotherapy (SABR), will be available in every hospital in England by the end of the financial year, and will improve the lives of thousands of cancer patients across the country. It was a fantastic result of campaigners, and reinforces the undeniable fact that our health service can continue to deliver the very best care for patients, even against the backdrop of the health crisis we find o...

UVC lamp for surface disinfection launched

Laser Components has introduced Blazar from Bolb, a ready-to-use UVC lamp for surface disinfection.  The unit is the size of a handheld spotlight and emits 2.0WOpt of UVC radiation thanks to the combined powers of 25 Germicidal LEDs. A cone-shaped reflector provides a beam angle of 55°.  Blazar’s disinfection performance has been proven in several studies. For example, the Guangzhou Institute of Microbiology achieved a reduction factor of Log4 (99.99%) for the human coronavirus hCoV-229E at a distance of one metre and an irradiation time of 60 seconds. This reduction value can vary greatly from pathogen to pathogen.   As soon as it is connected to...

UK-Rapid Test Consortium reaches “design freeze” for antibody test

The UK-Rapid Test Consortium (UK-RTC), a group of UK scientists and medical manufacturers led by Abingdon Health, has reached “design freeze” for its COVID-19 antibody test. The UK-RTC was set up in April 2020 to develop and manufacture COVID-19 antibody tests to determine if someone’s immune system has responded to infection from COVID-19. This milestone means the technical design and manufacturing specifications for the antibody testing kit are complete and so preparation for mass production can begin.   It would usually take ten months to reach this point. It has been delivered in ten weeks by Abingdon Health’s R&D team, working with Oxford University. The antibody test is being developed for the UK Department of Health and Social Care in response to the government’s ...

Display systems provider enhances embedded solutions capability

Display solutions and embedded systems provider, Review Display Systems (RDS) has announced the availability of complementary industrial specification SBC (single board computers) and TFT (thin film transistor) display modules for use in the design and development of integrated embedded systems. RDS is supplying and supporting European-manufactured, industrial specification SBCs from Kontron, an embedded computing technology firm, and TFT display modules from Taiwanese-based display manufacturer P.G Display Electronics. RDS is providing a complete embedded design and configuration capability that includes the integration of computing hardware, displays,  touchscreens, interconnect, mechanical fixtures and fittings, and custom operating systems and software.   ...